Table 2.
Demographic information of datasets T2.1, T2.2, T2.3 and T1.1.
| T2.1. - Farming for Life * | T2.2. - Digital Health | T2.3 - Glucotypes | T1.1. -REPLACE-BG | |||
|---|---|---|---|---|---|---|
| Paired A1c | Used Data | All/Used | All | All** | Used Data | |
| Participants | At-risk/pre-diabetes or T2D | At-risk/pre-diabetes or T2D | At-risk/pre-diabetes or T2D | Normoglycemic/pre-diabetes or T2D | T1D | T1D |
| n | 247 | 105 | 36 | 57 | 226 | 60 |
| Age - Mean (SD) | 54.2 ± 11.9 | 54.4 ± 11.8 | 49.9 ± 12 | 48.9 ± 14 | 44 ± 14 | 48.6 ± 13.6 |
| BMI - Mean (SD) | 31.3 ± 6 | 30 ± 5.1 | 32.7 ± 5.5 | 26.7 ± 4.7 | 27.3 ± 4.4 | 27.2 ± 4 |
| Gender | ||||||
| Female | 187 (75.7%) | 77 (73.3%) | 28 (77.8%) | 32 (56.1%) | 112 (49.6%) | 27 (45%) |
| Male | 60 (24.3%) | 28 (26.7%) | 8 (22.2%) | 25 (43.9%) | 114 (50.4%) | 33 (55%) |
| Race/Ethnicity | ||||||
| Non-Hispanic White | 33 (13.4%) | 9 (8.6%) | 0 | - | 207 (91.6%) | 54 (90%) |
| Hispanic or Latino | 208 (84.2%) | 96 (91.4%) | 36 (100%) | - | 9 (4.0%) | 3 (0.05%) |
| Black/African American | 3 (1.2%) | 0 | 0 | - | 5 (2.2%) | 2 (3%) |
| Asian | 3 (1.2%) | 0 | 0 | - | 4 (1.8%) | 0 |
| Other/ Unknown | 0 | 0 | 0 | 57 (100%) | 1 (0.4%) | 1 (1.7%) |
| Laboratory HbA 1c | ||||||
| HbA1c < 5.7% | 79 (31.9%) | 38 (36.2%) | 13 (36.1%) | 44 (77.2%) | 7 (3.1%) | 2 (3.3%) |
| 5.7%≤ HbA1c ≤ 6.4% | 90 (36.4%) | 35 (33.3%) | 9 (25%) | 9 (15.8%) | 35 (15.5%) | 7 (11.7%) |
| HbA1c > 6.4% | 78 (31.6%) | 32 (30.5%) | 14 (38.9%) | 2 (3.5%) *** | 184 (81.4%) | 51 (85%) |
| Arm/Group | ||||||
| CGM only | NA | NA | NA | NA | 149 (65.9%) | 40 (66.7%) |
| CGM + BGM | NA | NA | NA | NA | 77 (34.1%) | 20 (33.3%) |
| Data Segments | ||||||
| CGM Length | 2 segments 10–14 days with 10 week gap | 2 weeks | 1 week | 2–10 week run-in phase + 6-month trial | 3 segments > 60 days | |
| HbA1c | NA | t0 and t3 | t0 | t0 | NA | t1, t2, t3 |
| NCT | NCT03940300 | NCT04820348 | - | NCT02258373 | ||
*at enrollment.
**From A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes - Study Results - ClinicalTrials.gov.
*** 2 participants with unknown HbA1c were not used in the analysis.